mci-196 has been researched along with Weight Gain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irie, J; Itoh, H; Morimoto, K; Sugizaki, T; Watanabe, M | 1 |
| Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
| Cohen, LH; Havekes, LM; Kelder, T; Pieterman, EJ; Princen, HM; Sakai, K; Shimada, H; Sugimoto-Kawabata, K; Suzuki, K; van den Hoek, AM | 1 |
3 other study(ies) available for mci-196 and Weight Gain
| Article | Year |
|---|---|
Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Blotting, Western; Diet, High-Fat; Epichlorohydrin; Fluorescent Antibody Technique; Gene Expression; Glucagon-Like Peptide 1; Imidazoles; Insulin; Intestinal Mucosa; Intestines; Male; Mice; Proprotein Convertase 1; Receptors, G-Protein-Coupled; Resins, Synthetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Weight Gain | 2016 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |
Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion.
Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Fatty Acids, Nonesterified; Feces; Glucose; Lipid Metabolism; Lipids; Mice; Weight Gain | 2013 |